Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Completed · Phase 2 · Has a placebo group
Conditions studied: Lower Eyelid Steatoblepharon (Excess Eyelid Fat)
In brief
This study will test whether XAF5 (XOPH5) ointment, applied once daily to the lower eyelids for 10 weeks, reduces the prominence of lower eyelid fat in adults with moderate to severe steatoblepharon (excess eyelid fat).
Key facts
- Study ID
- NCT02230761
- Run by
- Topokine Therapeutics, Inc.
- People needed
- 90
- Starts
- 2014-09-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2016-02-08
Who can join
Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Topokine Therapeutics Clinical Study Centers — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.